ALPS Medical Breakthroughs ETF Rating → Bill Clinton Backing Biden Replacement??? (From The Freeport Society) (Ad) Free SBIO Stock Alerts $34.12 +0.66 (+1.97%) (As of 10:38 AM ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings ALPS Medical Breakthroughs ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SBIO Aggregate RatingModerate Buy2.81Holdings in SBIO have an aggregate rating of Moderate Buy based on 401 analyst ratings issued in the past year covering 50 companies (84.1% of the portfolio).SBIO Aggregate Price Target$50.4447.84% UpsideHigh Prediction$67.12Average Prediction$50.44Low Prediction$35.35Holdings in SBIO have an aggregate price target of $50.44 and a range of $35.35 to $67.12 covering 50 companies (84.1% of the portfolio).SBIO Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy24 Buy rating(s)Moderate Buy21 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ALPS Medical Breakthroughs ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 SBIO Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.30%VKTXViking Therapeutics$71.15-3.4%5 of 5 stars3.00$112.25 57.8%105.25%CERECerevel Therapeutics$42.11-0.2%1 of 5 stars2.11$42.67 1.3%9Short Interest ↓Positive News4.47%PCVXVaxcyte$65.07-0.2%1 of 5 stars3.00$78.50 20.6%4Earnings ReportAnalyst Revision4.03%RVMDRevolution Medicines$37.35+0.3%4 of 5 stars3.10$41.60 11.4%10Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage2.88%ALPNAlpine Immune Sciences$64.942 of 5 stars2.27$50.33 -22.5%11Short Interest ↓Positive News2.81%ALKSAlkermes$24.52+2.0%5 of 5 stars2.50$35.38 44.3%10Positive News2.31%AXSMAxsome Therapeutics$73.96+2.0%4 of 5 stars2.92$121.92 64.8%13Analyst Revision2.29%SWTXSpringWorks Therapeutics$41.48+1.4%2 of 5 stars3.00$68.83 65.9%62.23%CRNXCrinetics Pharmaceuticals$47.82-0.4%4 of 5 stars2.92$58.42 22.2%12Earnings ReportAnalyst ForecastInsider SellingShort Interest ↓Gap Down2.08%XENEXenon Pharmaceuticals$41.41+2.1%3 of 5 stars3.00$59.11 42.7%9Earnings ReportAnalyst Forecast2.00%IDYAIDEAYA Biosciences$41.26+0.2%3 of 5 stars3.00$47.50 15.1%12Earnings ReportShort Interest ↑Analyst Revision1.98%IMCRImmunocore$58.20-1.3%2 of 5 stars2.87$82.00 40.9%15Earnings ReportShort Interest ↑Analyst RevisionNews Coverage1.87%ACADACADIA Pharmaceuticals$15.39+0.9%4 of 5 stars2.75$28.94 88.0%16Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews Coverage1.86%ACLXArcellx$49.63-0.2%3 of 5 stars3.00$78.20 57.6%12Earnings Report1.84%SMMTSummit Therapeutics$4.93+6.0%1 of 5 stars3.00$7.50 52.1%21.77%MRUSMerus$45.49+2.2%1 of 5 stars3.00$56.33 23.8%11Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.73%MLTXMoonLake Immunotherapeutics$42.24+3.2%3 of 5 stars2.75$74.46 76.3%12Earnings ReportAnalyst RevisionNews Coverage1.61%CORTCorcept Therapeutics$29.02+7.3%5 of 5 stars3.00$40.10 38.2%4Short Interest ↓1.59%CLDXCelldex Therapeutics$40.53+1.5%1 of 5 stars2.80$66.00 62.8%51.57%RYTMRhythm Pharmaceuticals$40.15+2.6%3 of 5 stars2.83$54.33 35.3%6Earnings Report1.51%VCELVericel$48.52+0.9%1 of 5 stars3.00$46.80 -3.5%6Earnings ReportAnalyst DowngradeAnalyst Revision1.50%ARVNArvinas$31.95+1.6%2 of 5 stars2.88$61.13 91.3%16Earnings ReportAnalyst Revision1.48%VERAVera Therapeutics$40.95-0.9%0 of 5 stars3.00$36.71 -10.3%8Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.46%DNLIDenali Therapeutics$19.21+4.9%4 of 5 stars2.89$40.22 109.4%9Earnings ReportShort Interest ↑Analyst RevisionNews Coverage1.42%KROSKeros Therapeutics$54.32+0.1%3 of 5 stars3.00$86.00 58.3%7Earnings ReportAnalyst RevisionNews Coverage1.41%GERNGeron$3.804 of 5 stars2.80$6.10 60.5%51.36%NTLAIntellia Therapeutics$26.37+7.8%4 of 5 stars2.69$66.77 153.2%13Analyst Forecast1.32%RNAAvidity Biosciences$26.53+2.2%1 of 5 stars3.00$38.29 44.3%7Analyst Forecast1.30%GLPGGalapagos$28.69+0.5%0 of 5 stars1.75$34.50 20.3%4Positive News1.22%SNDXSyndax Pharmaceuticals$21.47-1.3%3 of 5 stars2.91$34.42 60.3%11Earnings ReportAnalyst RevisionNews Coverage1.20%AGIOAgios Pharmaceuticals$32.88-0.4%2 of 5 stars2.50$35.00 6.4%4Positive News1.19%CPRXCatalyst Pharmaceuticals$16.17+1.4%5 of 5 stars3.00$26.71 65.2%5Analyst ForecastShort Interest ↑1.10%INBXInhibrx$34.05-0.7%2 of 5 stars2.00$27.00 -20.7%2Positive News1.07%ZLABZai Lab$22.17+10.4%2 of 5 stars3.00$64.22 189.7%5Earnings ReportNews CoverageGap Up1.02%EWTXEdgewise Therapeutics$17.99-1.9%1 of 5 stars3.00$31.20 73.4%5Short Interest ↑1.02%KURAKura Oncology$20.51-1.0%3 of 5 stars2.88$28.28 37.9%81.00%PTGXProtagonist Therapeutics$29.39+4.1%2 of 5 stars3.00$38.00 29.3%4Analyst Revision0.96%RCUSArcus Biosciences$17.46+4.5%2 of 5 stars2.88$41.25 136.3%8Earnings ReportAnalyst Revision0.96%MORFMorphic$29.12+1.7%4 of 5 stars2.67$51.50 76.9%60.95%NMRANeumora Therapeutics$9.07-1.3%1 of 5 stars2.86$22.57 148.9%7Earnings ReportAnalyst Revision0.89%DAWNDay One Biopharmaceuticals$16.25+1.6%3 of 5 stars2.86$37.67 131.8%7Short Interest ↑Analyst Revision0.85%VRNAVerona Pharma$14.79-0.4%2 of 5 stars3.00$33.60 127.2%4Analyst Forecast0.83%IRWDIronwood Pharmaceuticals$6.86-2.0%4 of 5 stars3.00$18.40 168.2%5Earnings ReportAnalyst ForecastShort Interest ↓Analyst Revision0.83%XNCRXencor$22.05-1.9%4 of 5 stars2.89$36.25 64.4%9Earnings ReportAnalyst ForecastAnalyst Revision0.82%TARSTarsus Pharmaceuticals$37.17+0.5%3 of 5 stars2.88$49.88 34.2%8Analyst ForecastAnalyst RevisionNews Coverage0.81%DCPHDeciphera Pharmaceuticals$25.45+0.4%3 of 5 stars2.30$24.17 -5.0%100.79%SLNOSoleno Therapeutics$43.64-3.0%4 of 5 stars3.00$60.33 38.3%6Upcoming EarningsAnalyst Forecast0.79%FDMT4D Molecular Therapeutics$26.14+1.7%3 of 5 stars3.00$44.22 69.2%10Analyst Forecast0.78%MNKDMannKind$4.39+1.6%2 of 5 stars3.00$8.00 82.2%3Earnings ReportAnalyst Revision0.78%MIRMMirum Pharmaceuticals$25.41+2.6%5 of 5 stars3.10$49.73 95.7%10Analyst ForecastAnalyst RevisionGap Down This page (NYSEARCA:SBIO) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersDoes this make you sick?Allegiance GoldThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsHow Biden has already won 2024Porter & CompanyBill Clinton Backing Biden Replacement???The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALPS Medical Breakthroughs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
